Health | Biotechnology | Pharmaceutical ... View Press Release · Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio ...
News
- Houston Medicine Magazine Headlines Powered By Business Wire
- SABCS: Eli Lilly's oral SERD Ember counts on Verzenio to broaden its glow - Fierce Biotech
Presented at the 2024 San Antonio Breast Cancer Symposium (SABCS), the data support past observations that SERDs tend to perform better in ESR1 ...
- SystImmune, Inc. to Present Updated BL-B01D1 Data in Breast Cancer at SABCS Congress 2024
(SystImmune), a clinical-stage biotechnology company, today announced ... San Antonio Breast Cancer Symposium (SABCS) 2024, taking place on ...
- Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib ... - StreetInsider
Gonzalez Convention Center in San Antonio, Texas. The poster presents ... Celcuity is a clinical-stage biotechnology company focused on ...
- Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant ... - Quantisnow
... SAN ANTONIO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc ... Biotechnology: Biological Products (No Diagnostic Substances). Health Care ...